These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33564966)

  • 21. Risk organ + LCH gets the one-two punch?
    Stine KC
    Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory LCH With Secondary Intracranial PNET: A Case Report and Review of Literature.
    Chayapathi V; Mahajan A; Kalra M
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):e117-e120. PubMed ID: 28859038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
    Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
    Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine.
    Özyörük D; Yozgat AK; Kaçar D; Yazal Erdem A; Işık M; Güzelküçük Z; Hacısalihoğlu Ş
    Tumori; 2021 Dec; 107(6):NP120-NP122. PubMed ID: 34423687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.
    Pardanani A; Phyliky RL; Li CY; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
    Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
    Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Chlorodeoxyadenosine to treat refractory histiocytosis X.
    Saven A; Figueroa ML; Piro LD; Rosenblatt JD
    N Engl J Med; 1993 Sep; 329(10):734-5. PubMed ID: 8102196
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan.
    Imamura T; Sato T; Shiota Y; Kanegane H; Kudo K; Nakagawa S; Nakadate H; Tauchi H; Kamizono J; Morimoto A
    Int J Hematol; 2010 May; 91(4):646-51. PubMed ID: 20361277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
    Baumann M; Cerny T; Sommacal A; Koeberle D
    Hematol Oncol; 2012 Jun; 30(2):101-4. PubMed ID: 21732400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seventy-nine-year-old man with Langerhans cell histiocytosis treated with cladribine.
    Black A; Bershow A; Allen PS; Crowson AN
    J Am Acad Dermatol; 2011 Sep; 65(3):681-683. PubMed ID: 21839340
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment advances in pediatric relapsed and refractory Langerhans cell histiocytosis].
    Li HH; Xu XJ
    Zhonghua Er Ke Za Zhi; 2021 Nov; 59(11):993-996. PubMed ID: 34711040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cladribine therapy in adults with advanced Langerhans cell histiocytosis.
    Schini M; Makras P; Kanakis G; Voulgarelis M; Kaltsas G
    Leuk Lymphoma; 2013 Jul; 54(7):1541-3. PubMed ID: 23101752
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
    Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
    Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indeterminate cell histiocytosis - disappearance of skin infiltration following electron beam therapy and an application of 2-chlorodeoxyadenosine: case report].
    Adam Z; Ježová M; Šlampa P; Křen L; Vašků V; Koukalová R; Řehák Z; Pour L; Krejčí M; Král Z; Mayer J
    Vnitr Lek; 2017; 63(4):284-288. PubMed ID: 28520453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy.
    Lazor R; Etienne-Mastroianni B; Khouatra C; Tazi A; Cottin V; Cordier JF
    Thorax; 2009 Mar; 64(3):274-5. PubMed ID: 19252036
    [No Abstract]   [Full Text] [Related]  

  • 39. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis.
    Lorillon G; Bergeron A; Detourmignies L; Jouneau S; Wallaert B; Frija J; Tazi A
    Am J Respir Crit Care Med; 2012 Nov; 186(9):930-2. PubMed ID: 23118088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.